Journal
CELL HOST & MICROBE
Volume 30, Issue 12, Pages 1660-1661Publisher
CELL PRESS
DOI: 10.1016/j.chom.2022.11.009
Keywords
-
Categories
Ask authors/readers for more resources
This study successfully stabilized the presentation of LASV immunogens and induced the production of broadly neutralizing antibodies using a novel nanoparticle strategy.
The development of Lassa virus (LASV) vaccines has been challenging due to the instability of recombinant immunogens. In this issue of Cell Host & Microbe, Brouwer et al. use a two-component nanoparticle strategy that enables stable trimeric presentation of the LASV glycoprotein complex (GPC) and induction of broadly neutralizing antibodies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available